|
Index | - | P/E | - | EPS (ttm) | -0.12 | Insider Own | 1.80% | Shs Outstand | 88.32M | Perf Week | -39.81% |
Market Cap | 421.59M | Forward P/E | - | EPS next Y | - | Insider Trans | 0.00% | Shs Float | 78.14M | Perf Month | -38.24% |
Income | -9.30M | PEG | - | EPS next Q | - | Inst Own | 4.10% | Short Float | 6.23% | Perf Quarter | 78.71% |
Sales | 1.90M | P/S | 221.89 | EPS this Y | 22.50% | Inst Trans | -0.84% | Short Ratio | 0.85 | Perf Half Y | 49.73% |
Book/sh | 0.12 | P/B | 23.50 | EPS next Y | - | ROA | -68.10% | Target Price | - | Perf Year | 14.63% |
Cash/sh | 0.07 | P/C | 43.02 | EPS next 5Y | - | ROE | -75.30% | 52W Range | 0.99 - 8.40 | Perf YTD | 13.25% |
Dividend | - | P/FCF | - | EPS past 5Y | -40.90% | ROI | -87.50% | 52W High | -69.40% | Beta | - |
Dividend % | - | Quick Ratio | 8.70 | Sales past 5Y | 40.60% | Gross Margin | - | 52W Low | 159.60% | ATR | 0.81 |
Employees | 94 | Current Ratio | 9.80 | Sales Q/Q | 50.00% | Oper. Margin | - | RSI (14) | 33.11 | Volatility | 19.51% 16.51% |
Optionable | No | Debt/Eq | 0.00 | EPS Q/Q | 63.30% | Profit Margin | - | Rel Volume | 0.55 | Prev Close | 2.82 |
Shortable | Yes | LT Debt/Eq | 0.00 | Earnings | - | Payout | - | Avg Volume | 5.73M | Price | 2.57 |
Recom | - | SMA20 | -50.09% | SMA50 | -39.72% | SMA200 | 1.77% | Volume | 3,163,428 | Change | -8.87% |
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers VectorVision, which develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing; CSV-1000, an instrument for contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy; CSV-2000, a digital standardized contrast sensitivity testing device; and MapcatSF, a medical device that measures the macular pigment optical density. The company distributes its products through sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite